Indication for Anti-TNF-alpha Treatment in Patients With Ankylosing Spondylitis in Spain

Statistics

Indicación de terapia anti-TNF alfa en pacientes con espondilitis anquilosante en España

Pilar Font Ugaldea, Elisa Munoz Gomarizb, Eduardo Collantes Estevezc,

,1, on behalf of the ISSAS Spanish Group

a Departamento de Medicina, Universidad de Córdoba, Córdoba, Spain

b Unidad de Investigación, Hospital Universitario Reina Sofía, Córdoba, Spain

c Servicio de Reumatología, Hospital Universitario Reina Sofía, Cordoba, Spain

Read

5888

Times
was read the article

2932

Total PDF

2956

Total HTML

Share statistics

Article information

ISSN: 21735743
Original language: English

DOI:10.1016/S2173-5743(07)70260-5

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 6	1	10	11
2025 5	64	89	153
2025 4	55	26	81
2025 3	52	31	83
2025 2	48	38	86
2025 1	66	74	140
2024 12	21	41	62
2024 11	30	72	102
2024 10	21	31	52
2024 9	22	21	43
2024 8	37	37	74
2024 7	28	32	60
2024 6	27	32	59
2024 5	27	23	50
2024 4	29	22	51
2024 3	39	33	72
2024 2	24	24	48
2024 1	24	21	45
2023 12	21	38	59
2023 11	15	23	38
2023 10	33	28	61
2023 9	22	30	52
2023 8	18	20	38
2023 7	19	27	46
2023 6	19	21	40
2023 5	19	8	27
2023 4	13	14	27
2023 3	18	21	39
2023 2	19	30	49
2023 1	16	21	37
2022 12	21	27	48
2022 11	21	26	47
2022 10	19	27	46
2022 9	22	30	52
2022 8	19	32	51
2022 7	20	38	58
2022 6	20	36	56
2022 5	25	39	64
2022 4	24	44	68
2022 3	20	46	66
2022 2	17	31	48
2022 1	22	41	63
2021 12	19	42	61
2021 11	19	55	74
2021 10	25	45	70
2021 9	23	45	68
2021 8	18	28	46
2021 7	17	39	56
2021 6	25	41	66
2021 5	25	35	60
2021 4	55	55	110
2021 3	32	19	51
2021 2	34	19	53
2021 1	30	25	55
2020 12	23	14	37
2020 11	22	21	43
2020 10	15	7	22
2020 9	35	13	48
2020 8	21	14	35
2020 7	19	7	26
2020 6	25	14	39
2020 5	19	12	31
2020 4	18	11	29
2020 3	14	13	27
2020 2	1	0	1
2020 1	9	0	9
2019 9	6	0	6
2019 6	2	0	2
2019 3	2	0	2
2019 1	1	0	1
2018 5	2	1	3
2018 4	14	10	24
2018 3	13	17	30
2018 2	11	5	16
2018 1	2	6	8
2017 12	11	6	17
2017 11	6	15	21
2017 10	9	7	16
2017 9	8	3	11
2017 8	7	7	14
2017 7	10	13	23
2017 6	20	15	35
2017 5	19	11	30
2017 4	14	10	24
2017 3	18	4	22
2017 2	9	8	17
2017 1	11	8	19
2016 12	31	16	47
2016 11	12	5	17
2016 10	33	6	39
2016 9	20	12	32
2016 8	26	6	32
2016 7	14	10	24
2016 4	1	0	1
2016 3	2	0	2
2015 12	2	0	2
2015 9	3	0	3
2015 8	1	0	1
2015 7	8	4	12
2015 6	16	13	29
2015 5	17	24	41
2015 4	16	22	38
2015 3	14	15	29
2015 2	18	19	37
2015 1	11	19	30
2014 12	18	21	39
2014 11	13	19	32
2014 10	12	41	53
2014 9	11	24	35
2014 8	21	23	44
2014 7	12	36	48
2014 6	40	36	76
2014 5	25	34	59
2014 4	35	56	91
2014 3	40	47	87
2014 2	36	29	65
2014 1	23	28	51
2013 12	25	24	49
2013 11	20	35	55
2013 10	37	46	83
2013 9	22	12	34
2013 8	23	31	54
2013 7	22	11	33
2013 6	29	12	41
2013 5	25	23	48
2013 4	23	27	50
2013 3	17	14	31
2013 2	20	19	39
2013 1	25	7	32
2012 12	17	11	28
2012 11	12	9	21
2012 10	5	8	13
2012 9	7	3	10
2012 7	1	0	1
2012 6	2	0	2
2012 5	1	0	1
2012 4	3	0	3
2012 3	3	0	3
2012 2	2	0	2
2012 1	2	0	2
2011 12	4	0	4
2011 11	5	0	5
2011 10	1	0	1
2011 9	2	0	2
2011 8	1	0	1
2011 7	2	0	2
2011 6	4	0	4
2011 3	1	0	1
2011 2	6	0	6
2011 1	3	0	3
2010 12	7	0	7
2010 11	3	0	3
2010 10	4	0	4
2010 9	3	0	3
2010 8	3	0	3
2010 7	3	0	3
2010 5	9	0	9
2010 4	7	0	7
2010 3	4	0	4
2010 2	6	0	6
2010 1	5	0	5
2009 12	13	0	13
2009 11	23	0	23
2009 10	21	0	21
2009 9	14	0	14
2009 8	9	0	9
2009 7	13	0	13
2009 6	8	0	8
2009 5	13	0	13
2009 4	28	0	28
2009 3	22	0	22

Show all

Indexed in:

Follow us:

Subscribe:

Statistics

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter